Barman Apurba, Mukherjee Somnath, Sinha Mithilesh K, Sahoo Jagannatha, Viswanath Amrutha
Department of Physical Medicine and Rehabilitation, All India Institute of Medical Sciences, Bhubaneswar, India.
Department of Transfusion Medicine, All India Institute of Medical Sciences, Bhubaneswar, India.
Clin Shoulder Elb. 2021 Dec;24(4):215-223. doi: 10.5397/cise.2021.00381. Epub 2021 Nov 11.
The objective of this study was to compare the efficacy of platelet-rich plasma (PRP) injection with an institution-based physical therapy (PT) program for adhesive capsulitis (AC) of the shoulder in patients with diabetes mellitus (DM).
A total of seventy diabetic patients with AC of the shoulder for <6 months were assigned to two groups: PRP group and PT group. In the PRP group, 35 patients were administered a single shot of PRP (4 mL) into the glenohumeral joint. In the PT group, 35 patients were given institution-based PT that included 10 30-minute sessions of planned PT over a 2-week period. After the interventions, all patients were prospectively followed for 12 weeks. Intensity of shoulder pain, function, and range of motion were assessed at baseline and then at 3, 6, and 12 weeks.
Thirty-three patients in the PRP group and 32 in the PT group completed the 12-week study. At 12 weeks, patients who received PRP injections showed greater improvement in shoulder pain (p<0.001) than those recruited to the PT group. In the range of motion and shoulder function activities, patients in the PRP group showed significant improvement compared with the institution-based PT group (p<0.001). No significant complications were reported from any groups.
In a diabetic population, PRP injections significantly improved shoulder pain and function compared with an institution-based PT program for shoulder AC. Additionally, it is a safe and well-tolerated method for AC management for diabetic patients.
本研究的目的是比较富血小板血浆(PRP)注射与基于机构的物理治疗(PT)方案对糖尿病(DM)患者肩部粘连性关节囊炎(AC)的疗效。
总共70例肩部AC病程小于6个月的糖尿病患者被分为两组:PRP组和PT组。PRP组中,35例患者接受了一次向盂肱关节注射4 mL PRP的治疗。PT组中,35例患者接受了基于机构的PT治疗,包括在2周内进行10次每次30分钟的计划性PT治疗。干预后,对所有患者进行为期12周的前瞻性随访。在基线时以及之后的第3、6和12周评估肩部疼痛强度、功能和活动范围。
PRP组33例患者和PT组32例患者完成了为期12周的研究。在第12周时,接受PRP注射的患者在肩部疼痛方面的改善程度(p<0.001)高于PT组患者。在活动范围和肩部功能活动方面,PRP组患者与基于机构的PT组相比有显著改善(p<0.001)。各小组均未报告严重并发症。
在糖尿病患者群体中,与基于机构的肩部AC PT方案相比,PRP注射能显著改善肩部疼痛和功能。此外,对于糖尿病患者的AC治疗,这是一种安全且耐受性良好的方法。